The exosome industry is experiencing unprecedented growth—and unprecedented challenges.

Search interest in exosomes has surged over 400% since 2023, with Florida, California, and the Northeast leading consumer demand. Yet media coverage struggles to distinguish between legitimate therapeutic innovation and unsubstantiated marketing claims. Recent developments, including Florida's expanded stem cell legislation and the proliferation of direct-to-consumer exosome clinics, underscore the urgent need for accurate, science-based reporting.

EXACT provides journalists with verified information and expert perspectives on exosome science, regulation, and clinical applications. Our team includes researchers who have published the definitive studies on exosome storage and characterization, clinicians treating patients with these therapies, and industry experts tracking the $2.8 billion projected market growth.

 

Current media topics we can address:

• The critical difference between human-derived and plant/animal exosomes

• How to evaluate exosome product claims (red flags vs. legitimate science)

• State regulatory variations and their impact on patient safety

• The 2.7 million misleading social media posts identified in our recent analysis

​

We welcome members of the press to get in touch - we'd be happy to arrange a discussion.

​